General procedures Synthesis
All reagents were purchased from commercial sources and used without additional purification. Tetrahydrofuran was freshly distilled under nitrogen from the sodium radical anion of benzophenone. All other anhydrous solvents were purchased or obtained from in-house solvent purification towers. All reactions were conducted in flame-dried glassware under an inert atmosphere of nitrogen or argon. Brine is a saturated aqueous solution of sodium chloride. Solvent evaporation was performed using a rotary evaporator under reduced pressure.
TLCs were performed on Merck silica gel 60 F 254 and visualized by UV lamp or aqueous alkaline potassium permanganate solution. Column chromatography was performed on silica gel Aldrich 60 or Merck aluminium oxide 90. Preparative thin layer chromatography was performed on Merck 60 silica gel plates. 1 H and 13 C NMR spectral data were recorded using a Bruker DPX400, Bruker AV400 and Bruker AV(III)400 spectrometers. Chemical shifts are quoted in ppm downfield from tetramethylsilane as internal standard. Coupling constant J values are given in Hertz. Infrared spectral data were recorded using a Perkin-Elmer 1600 FTIR spectrometer. Mass spectral data were recorded using the open-access Bruker MicroTOF spectrometer. Melting points are uncorrected and were recorded using Stuart Scientific SMP3.
Biological assay Materials and Methods:
Cells:
TE671 cells expressing human muscle-type nicotinic acetylcholine receptors were cultured in Dulbecco's modified Eagles Medium (DMEM) with 10% foetal calf serum (FCS), 2 mM glutamine and 10 IU/ml penicillin and 10µg/ml streptomycin. Cultures were passaged weekly and plated in 35mm Petri dishes over glass coverslips (5x20mm) in 2ml of DMEM. These were kept in a 36.5˚C incubator with 5% C0 2 . After 20 passages the culture was re-derived from stock stored in liquid nitrogen. For recordings, confluent coverslips were transferred to a perfusion chamber with mammalian ringer (135 mM NaCl, 5.4 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 5 mM HEPES, 10 mM D-glucose adjusted to pH 7.4 with NaOH) flowing at 5 ml/min.
Whole-cell patch-clamp:
Patch pipettes were pulled to ~5MΩ using a P-97 Flaming/Brown micropipette puller (Sutter Instrument Co., USA) from boroscilicate glass capillaries (World Precision Instruments, USA) and filled with cesium pipette solution (140mM CsCl, 1mM MgCl2, 11mM EGTA and 5mM HEPES, pH 7.2). Whole-cell currents were monitored using an Axopatch 200 (Axon instruments, USA) patch-clamp amplifier and recorded to the hard disk of a Viglen computer using WinWCP V4.1.3 software (University of Strathclyde). Pyrrolizidines were dissolved in dimethyl sulfoxide (DMSO) to create a 100 mM stock. Working concentrations from 1 mM to 100 nM were made in mammalian ringer containing 10 µM acetylcholine. To control for any effects of the solvent, DMSO was added to all solutions to a final concentration of 1%. Stock and working solutions were stored at -20˚C when not in use.
Pyrrolizidines were co-applied with 10 µM ACh in 1 s pulses using a DAD-12 Superfusion system (Adams and List Associates, USA) fitted with a 100 µm polyamide coated quartz output tube. To perfuse cells, the output tube was manoeuvred so that the aperture was facing the cell such that test solutions flowed over and round the cell. Both the amplifier and perfusion system were controlled by WinWCP V4.1.3 software (University of Strathclyde). A wash-off of mammalian ringer was constantly flowing from the tip of the perfusion manifold at ~3ml/hr between ACh applications. ACh and test compounds were applied at 400 mm/Hg with a 60 s wash-off between applications. 10 µM ACh was applied after each ACh/pyrrolizidine application. All recordings were taken at room temperature (22˚C-25˚C).
Data analysis:
ACh elicited currents were measured 1s after onset. 
To a solution of the diamide 5 (0.500 g, 1.42 mmol) in dry THF (15 mL) a solution of N-propylmagnesium bromide 2M solution in diethyl ether (7.09 mL, 14.2 mmol) was added dropwise at room temperature. The solution was stirred for 15 hours and concentrated under reduced pressure. The brown residue then charged with dichloromethane (10 mL). At 0°C, the solution was charged with aqueous 2M HCl (15 mL). The resulting mixture was extracted with dichloromethane (3 X 25 mL). The combined organic layers were washed with brine (30 mL), dried over magnesium sulfate, and concentrated in vacuo. (±) Xenovenine 2
To a solution of 8 (100 mg, 0.391 mmol) in dry methanol (10 mL) was added ammonium acetate (97 mg, 1.258 mmol). After 15 min, sodium cyanoborohydride (123 mg, 1.955 mmol) was added. The reaction mixture was stirred for 14 h at room temperature. Water (10 mL) was added to quench excess sodium cyanoborohydride and methanol was evaporated in vacuo. The aquous layer was extracted with ethyl acetate (3 X 30 mL) and the combined organic layers were washed with brine, dried over potassium carbonate, and concentrated in vacuo. The yellow oil obtained was purified by flash chromatography on alumina eluting with 5% to 20% ethyl acetate in petroleum ether, giving 2 as a colorless oil ( 
